Cardiovascular risk assessment: The key path toward precision prevention
Chronic Diseases and Translational Medicine · 2023-12 · 9 (4) · 273-276
DOI: 10.1002/cdt3.90 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chronic Diseases and Translational Medicine, 2023-08. Verfasst von Jianxin Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical …. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
- Key Laboratory of Cardiovascular Epidemiology Chinese Academy of Medical Sciences Beijing China.
ORCID-Profile: Xiangfeng Lu
Zitieren
APA
Li, J., & Lu, X. (2023). Cardiovascular risk assessment: The key path toward precision prevention. Chronic Diseases and Translational Medicine, 9(4), 273-276. https://doi.org/10.1002/cdt3.90
Vancouver
Li J, Lu X. Cardiovascular risk assessment: The key path toward precision prevention. Chronic Diseases and Translational Medicine. 2023;9(4):273-276. doi:10.1002/cdt3.90
BibTeX
@article{Li2023,
author = {Li, Jianxin and Lu, Xiangfeng},
title = {Cardiovascular risk assessment: The key path toward precision prevention},
journal = {Chronic Diseases and Translational Medicine},
year = {2023},
volume = {9},
number = {4},
pages = {273--276},
doi = {10.1002/cdt3.90}
}
EUVIMED